Evan Loh, CEO at Paratek Pharmaceuticals, Inc. (PRTK), sold 174,152 shares at $4.27 ($753K) on 2021-12-15, disclosed to the SEC on 2021-12-15.
Tax-driven sale ($753k) by CEO — typically RSU/option vesting with shares sold to cover withholding tax. Not a directional view.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.42 | 13,983 | $62K | 8.2% |
| 2 | $4.42 | 13,983 | $62K | 8.2% |
| 3 | $4.37 | 23,834 | $104K | 13.8% |
| 4 | $4.37 | 23,834 | $104K | 13.8% |
| 5 | $4.27 | 49,259 | $210K | 27.9% |
| 6 | $4.27 | 49,259 |
| $210K |
| 27.9% |
| Total | $4.32 avg | 174,152 | $753K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $393K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $31K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $237K | — | Filing → |